| MERTK |
MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.632 |
Evidence |
|
| MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.632 |
Evidence |
|
| MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.632 |
Evidence |
|
| TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
RIN1 |
RIN1: Ras and Rab interactor 1 |
0.632 |
Evidence |
|
| CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
TSHR |
IPI00386365 |
0.632 |
Evidence |
|
| CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.632 |
Evidence |
O
|
| CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.632 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
0.632 |
Evidence |
|
| CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
PKP3 |
PKP3: Plakophilin-3 |
0.632 |
Evidence |
|
| F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.632 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
0.632 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
0.632 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.632 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
0.632 |
Evidence |
|
| BMX |
IPI00514142 |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
0.632 |
Evidence |
|
| BMX |
IPI00514142 |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
0.632 |
Evidence |
|
| BMX |
IPI00514142 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.632 |
Evidence |
|
| CCL11 |
CCL11, SCYA11: Eotaxin precursor |
TSHR |
IPI00386365 |
0.632 |
Evidence |
|
| P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.632 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.632 |
Evidence |
|
| HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
0.632 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.632 |
Evidence |
|
| XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
0.632 |
Evidence |
|